Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Retension Pharmaceuticals, Inc.

NASDAQ: RTSN · Life Sciences · 3 alerts · CIK 2002988

Share price
$11.46Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Retension Pharmaceuticals, Inc. filings on SEC EDGAR ↗

6:01 AM ET 8-K
Executive Compensation

Retension Pharmaceuticals Executive Compensation

Retension Pharmaceuticals appointed Robert Wong as Vice President and Chief Accounting Officer, effective November 2, 2026. His compensation package includes an annual base salary of $360,000, a 30% target bonus opportunity, a $20,000 sign-on bonus, and a stock option award for 25,000 shares.

Counterparty
Robert Wong
6:12 PM ET Form 4
Insider Buying

Retension Pharmaceuticals CEO Eric L. Keller Buys $250K of Stock

Eric L. Keller, CEO, bought 20,800 shares of Retension Pharmaceuticals, Inc. at $12.00 a share, worth $250K in total on Oct 13, 2026. Shares held after the trade: 423,377 (+5.2%).

Value
$250K
Shares
20,800
Price
$12.00
Role
CEO
Holding change
+5.2%
Trade date
Oct 13, 2026
6:11 PM ET Form 4
Insider Buying

Retension Pharmaceuticals Insider Franklin M. Berger Buys $120K of Stock

Franklin M. Berger bought 10,000 shares of Retension Pharmaceuticals, Inc. at $12.00 a share, worth $120K in total on Oct 13, 2026. Shares held after the trade: 10,000.

Value
$120K
Shares
10,000
Price
$12.00
Trade date
Oct 13, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.